CD4 and cancer: Besides, the presence of CCL4 in NK cells, along with its receptor SLC7A1 in cancer cells, and CCR8 in CD4 + naïve T cells/Treg cells signified an activation of NK cells [82], which may predict a more favorable pathological response in pCR patients before NAT.